Core outcomes stratified by AUS score
| AUS: 0 (n=72) | AUS: 1 (n=230) | AUS: 2 (n=243) | AUS: 3 (n=186) | |
| Duration of intravenous antibiotics (days) n; median (IQR) | 69; 3 (1, 5) | 209; 3 (2, 6) | 216; 4 (3, 8) | 169; 7 (3, 11) |
| Duration from episode to discharge (hours) n; median (IQR) | 71; 72 (28, 228) | 226; 96 (52, 192) | 238; 120 (72, 240) | 178; 192 (78, 336) |
| Outcomes | ||||
| Positive blood culture (excl contaminants) | 12 (17%) | 36/229 (16%) | 49 (20%) | 57 (31%) |
| Significant infection requiring intravenous antibiotics | 13 (18%) | 29/229 (13%) | 56 (23%) | 57 (31%) |
| Representation within 7 days | 5 (7%) | 25 (11%) | 12 (5%) | 17 (9%) |
| Readmission within 7 days | 5 (7%) | 22 (10%) | 11 (5%) | 16 (9%) |
| ICU admission | 0 (0%) | 2/229 (1%) | 4 (2%) | 8 (4%) |
| Death from infection | 0 (0%) | 0/229 (0%) | 0 (0%) | 2 (1%) |
| Death from other cause | 0 (0%) | 0/229 (0%) | 3 (1%) | 2 (1%) |
All data are count (%), unless otherwise specified.
AUS, Australian-UK-Swiss; ICU, intensive care unit.